Agile Therapeutics reported $6.14M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Adma Biologics ADMA:US USD 34.91M 17.51M
Agile Therapeutics AGRX:US USD 6.14M 6.88M
Bayer BAYN:GR EUR 4.36B 949M
Biomarin Pharmaceutical BMRN:US USD 761.52M 141.71M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Pacira Pharmaceuticals PCRX:US USD 109.42M 12.64M
Pain Therapeutics PTIE:US USD 174.66M 22.57M
Teva Pharmaceutical Industries TEVA:US USD 2.22B 167M